Literature DB >> 21174138

Parkinson's disease in China.

You-yong Tian1, Cui-ju Tang, Jie Wu, Jun-shan Zhou.   

Abstract

Paralysis agitans was first documented in 1817 by James Parkinson, and therefore the syndrome was named Parkinson's disease (PD). In fact, as early as more than 2000 years ago, the clinical manifestations of this disease have been described in Chinese medicine classics, such as the "Huangdi Neijing (Yellow Emperor's Internal Classic)" and "Zhong Zang Jing (Hua's Zhong Zang Classic)." In recent years, especially in the past 30 years after reform and opening-up, PD has drawn a lot of attention by Chinese scholars. Although great progress in the studies of PD has been made in recent years, the gap between China and western countries still exists. In this review, we concentrate on the main progress made in epidemic characteristics, etiology, diagnosis and management of PD in China.

Entities:  

Mesh:

Year:  2010        PMID: 21174138     DOI: 10.1007/s10072-010-0461-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  60 in total

1.  History of Chinese stereotactic and functional neurosurgery.

Authors:  B Sun; L Q Lang; P Y Cong; K Y Liu; L Pan
Journal:  Stereotact Funct Neurosurg       Date:  2001       Impact factor: 1.875

2.  The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.

Authors:  Cao Li; Zhang Ting; Xiao Qin; Wang Ying; Bai Li; Lu Guo Qiang; Ma Jian Fang; Zhang Jing; Ding Jian Qing; Chen Sheng Di
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

3.  Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.

Authors:  Rong Peng; Yinru Gou; Qiang Yuan; Tao Li; Helen Latsoudis; Guanggu Yuan; Deru Luo; Xiehe Liu; David A Collier
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

Review 4.  [Pathology of familial Parkinson's disease].

Authors:  Koichi Wakabayashi; Hitoshi Takahashi
Journal:  Brain Nerve       Date:  2007-08

5.  Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease.

Authors:  Guomei Tang; Mingyuan Zhang; Huijun Xie; Sanduo Jiang; Zucheng Wang; Lin Xu; Yixin Hao; Dayu Lin; Hekui Lan; Yinyu Wang; Lishan Chen; Daming Ren
Journal:  Neurosci Lett       Date:  2002-08-09       Impact factor: 3.046

6.  Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.

Authors:  E-K Tan; C Tan; S M C Fook-Chong; S Y Lum; A Chai; H Chung; H Shen; Y Zhao; M L Teoh; Y Yih; R Pavanni; V R Chandran; M C Wong
Journal:  J Neurol Sci       Date:  2003-12-15       Impact factor: 3.181

7.  Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population.

Authors:  Z-J Zhang; J-M Burgunder; X-K An; Y Wu; W-J Chen; J-H Zhang; Y-C Wang; Y-M Xu; Y-R Gou; G-G Yuan; X-Y Mao; R Peng
Journal:  Neurosci Lett       Date:  2008-07-10       Impact factor: 3.046

8.  The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.

Authors:  Chin-Song Lu; Yah-Huei Wu-Chou; Marina van Doeselaar; Erik J Simons; Hsiu-Chen Chang; Guido J Breedveld; Alessio Di Fonzo; Rou-Shayn Chen; Yi-Hsin Weng; Szu-Chia Lai; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2008-08-21       Impact factor: 2.660

9.  Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations.

Authors:  Ruey-Meei Wu; Din-E Shan; Chen-Ming Sun; Ren-Shyan Liu; Wuh-Liang Hwu; Chun-Hwei Tai; Jennifer Hussey; Andrew West; Katrina Gwinn-Hardy; John Hardy; Judy Chen; Matt Farrer; Sarah Lincoln
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

10.  Epidemiologic study of Parkinson's disease in Hong Kong.

Authors:  S C Ho; J Woo; C M Lee
Journal:  Neurology       Date:  1989-10       Impact factor: 9.910

View more
  6 in total

1.  Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.

Authors:  Lixue Chuan; Jie Gao; Yuying Lei; Raoxiang Wang; Lechun Lu; Xianyu Zhang
Journal:  Neurol Sci       Date:  2014-07-25       Impact factor: 3.307

2.  The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson's disease: a randomized, double-blind, double-dummy, parallel-group study.

Authors:  Ying Wang; Shenggang Sun; Suiqiang Zhu; Chunfeng Liu; Yiming Liu; Qing Di; Huifang Shang; Yan Ren; Changhong Lu; Mark Forrest Gordon; Nolwenn Juhel; Shengdi Chen
Journal:  Transl Neurodegener       Date:  2014-06-02       Impact factor: 8.014

3.  Breathing Signature as Vitality Score Index Created by Exercises of Qigong: Implications of Artificial Intelligence Tools Used in Traditional Chinese Medicine.

Authors:  Junjie Zhang; Qingning Su; William G Loudon; Katherine L Lee; Jane Luo; Brent A Dethlefs; Shengwen Calvin Li
Journal:  J Funct Morphol Kinesiol       Date:  2019-12-03

4.  Current clinical practice for Parkinson's disease among Chinese physicians, general neurologists and movement disorders specialists: a national survey.

Authors:  Wei Chen; Shuai Chen; Qin Xiao; Gang Wang; Sheng-Di Chen
Journal:  BMC Neurol       Date:  2012-12-07       Impact factor: 2.474

5.  Long-term Efficacy of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A 5-year Follow-up Study in China.

Authors:  Lu-Lu Jiang; Jin-Long Liu; Xiao-Li Fu; Wen-Biao Xian; Jing Gu; Yan-Mei Liu; Jing Ye; Jie Chen; Hao Qian; Shao-Hua Xu; Zhong Pei; Ling Chen
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

Review 6.  Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases.

Authors:  Rose Ghemrawi; Mostafa Khair
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.